Retinol binding protein expression is induced in HepG2 cells by zinc deficiency  by Satre, Michael A. et al.
Retinol binding protein expression is induced in HepG2 cells by
zinc de¢ciency
Michael A. Satrea;*, Katayoun Alavi Jessena, Michael S. Clegga, Carl L. Keenb
aDepartment of Nutrition, University of California, Davis, One Shields Avenue, Davis, CA 95616-8669, USA
bDepartment of Internal Medicine, University of California, Davis, One Shields Avenue, Davis, CA 95616-8669, USA
Received 16 October 2000; revised 6 February 2001; accepted 7 February 2001
First published online 15 February 2001
Edited by Veli-Pekka Lehto
Abstract Zinc (Zn) deficiency is often associated with low
plasma vitamin A (retinol) concentrations. It has been suggested
that the reduction in plasma retinol is secondary to reduced liver
retinol binding protein (RBP) synthesis. In the present study,
RBP expression was determined in HepG2 cells cultured in either
Zn adequate media or chelated media containing varying
concentrations of Zn. Levels of RBP mRNA increased in a
time- and Zn concentration-dependent manner such that 0.5 WM
Zn-treated cells exhibited a s 7.5-fold increase while cells
treated with 15 WM Zn were increased 2.9-fold at 72 h compared
to controls. RBP protein also progressively increased by 72 h to
levels s 8-fold and 3-fold higher than controls, in 0.5 WM and 15
WM Zn-treated cells, respectively. The increase in RBP occurred
without any change in DNA concentration between groups
through 72 h. The Zn deficiency-induced elevations in RBP
transcript levels could be reversed within 24^48 h of repletion in
Zn adequate media. Thus, the reductions in plasma retinol
observed in Zn deficiency are in part a direct consequence of the
deficiency. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Zinc (Zn) is essential to the function of numerous proteins
including its role as a component of the catalytic site(s) of
hundreds of enzymes [1]. Zn is also an essential component
of transcription factors wherein it serves an integral structural
role in DNA-contacting Zn ¢nger motifs [2]. This later prop-
erty suggests a possible role of Zn as a regulatory ion in gene
expression [3]. Indeed, recent studies have observed changes in
transcript levels of several genes in response to changes in Zn
status [4^8].
The e¡ects of Zn de¢ciency in both humans and experimen-
tal animals have been clearly established and are known to
result in abnormal development and growth failure [9]. An-
other common ¢nding in Zn de¢ciency is low plasma vitamin
A (retinol) levels which often occur despite normal to elevated
liver vitamin A (reviewed in [10]), suggesting that Zn de¢-
ciency impairs hepatic vitamin A mobilization. Since Zn sup-
plementation in de¢ciency has been shown to improve indica-
tors of vitamin A status including restoration of plasma
retinol to within the normal range [11], these Zn de¢ciency-
induced e¡ects on vitamin A may in some cases be reversible.
In humans, retinol is the major form of vitamin A in the
circulation where it is bound to the carrier molecule retinol
binding protein (RBP) [12]. Synthesized primarily in the liver,
RBP is integral to systemic vitamin A homeostasis, binding a
single retinol molecule and facilitating its delivery to, and
subsequent uptake by, vitamin A-dependent tissues [13,14].
Reductions in plasma RBP levels have been observed in Zn
de¢ciency [10] and there is a positive correlation between
plasma concentrations of retinol and/or RBP with plasma
Zn [11]. In aggregate, studies suggest that the reduction in
the circulating retinol concentration in Zn de¢ciency is a con-
sequence of reduced hepatic RBP synthesis and/or a reduction
in the release of retinol-RBP (holoRBP) from the liver. The
mechanism by which this occurs is, however, unknown.
Although Zn de¢ciency has been shown to result in an
overall depression of hepatic protein synthesis [15], mRNA
levels of a number of genes have been shown to be either
increased [4,6,8] or decreased [5,7,16,17] as a consequence of
Zn de¢ciency. Although Zn de¢ciency is associated with re-
ductions in plasma retinol and RBP, a study in rats observed
an increase in the relative abundance of liver RBP transcripts
as a consequence of Zn de¢ciency [15]. Whether this increase
in RBP mRNA manifested as an increase in RBP protein, or
is reversible with Zn supplementation, was not assessed. Pair-
fed animals, however, also exhibited an increase in hepatic
RBP mRNA, although to a lesser extent than in the Zn-de¢-
cient group [15]. This observation, together with those of oth-
er studies in which pair-fed animals also exhibited reductions
in plasma retinol (reviewed in [10]), suggests that the e¡ects of
Zn de¢ciency on vitamin A mobilization may not be a specif-
ic, direct response to Zn depletion, but rather may re£ect
indirect e¡ects secondary to Zn de¢ciency-induced anorexia.
It should be noted, however, that pair-fed animals also have
reduced Zn status as evidenced by reductions in plasma and
bone Zn concentrations compared to ad libitum, Zn adequate-
fed controls [15]. This highlights a limitation to interpretation
of results from whole animal studies wherein there is an in-
ability to de¢nitively distinguish the direct e¡ects of Zn de¢-
ciency from the indirect e¡ects resulting from decreased food
intake and associated hormonal alterations. Cell culture mod-
els allow for the study of Zn de¢ciency directly, in the absence
of these confounding factors.
Given the e¡ects of Zn de¢ciency on vitamin A, and the
recent evidence that Zn status can a¡ect the expression of
speci¢c genes, the present study was undertaken to determine
whether Zn status directly a¡ects the expression of RBP. Us-
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ing human RBP-expressing HepG2 cells as a model, in the
present study we characterized the time-dependent e¡ects of
di¡erent concentrations of Zn in the culture media on RBP
mRNA and protein levels as well as the response to Zn re-
pletion. We observed that culture of HepG2 cells in low Zn
media results in increases in RBP mRNA and protein, with
the magnitude and timing of these increases being correlated
to the extent of media Zn depletion. In addition, the Zn de-
¢ciency-induced elevations in RBP transcript levels were re-
versed by switching cells from Zn-de¢cient to Zn-supple-
mented media. These results support the concept that the
alterations in vitamin A levels observed in Zn de¢ciency are
in part a direct consequence of the de¢ciency.
2. Materials and methods
2.1. Materials
Human hepatoma (HepG2) cells were obtained from the American
Type Culture Collection (Rockville, MD, USA). Dulbecco’s modi¢ed
Eagle’s medium (DMEM), fetal bovine serum (FBS), and penicillin/
streptomycin were purchased from Gibco (Grand Island, NY, USA).
Phenylmethylsulfonyl £uoride and diethylenetriaminepentaacidic acid
(DTPA) were from Sigma (St. Louis, MO, USA).
2.2. Cell culture
HepG2 cells were maintained in DMEM supplemented with 7.5%
FBS and antibiotics (50 U/ml penicillin/streptomycin) at 37‡C in a
humidi¢ed atmosphere of 5% CO2 in air. For experiments, cells
were seeded in 100 mm2 tissue culture dishes at 1U106 cells/dish in
DMEM/7.5% FBS (designated as standard medium). Following a 12 h
initial attachment period, the standard media were removed by
aspiration and discarded, and the cells were carefully washed with
phosphate-bu¡ered saline (PBS). The media were then replaced with
either chelated media containing 0.5, 15, 50 WM Zn or unchelated
standard media (control) as indicated, and the cultures continued
for the indicated time periods. Duplicate or triplicate dishes were
used per media Zn concentration/time point and each experiment
was repeated at least twice.
Since FBS is the primary source of Zn in culture media, Zn-de¢-
cient FBS was prepared by chelation with DTPA as described previ-
ously [18]. Using this method, the concentration of Zn in the chelated
serum was reduced to 2.5 WM as determined by inductively coupled
plasma atomic absorption/emission spectroscopy analysis (Trace Scan,
Thermo Jarrell Ash Corp., Franklin, MA, USA). Copper and iron
concentrations were ¢xed at 1 WM and 5 WM, respectively, to remove
these metals as variables in these studies. The chelated FBS was di-
luted with DMEM (DMEM has 6 0.1 WM Zn) to a ¢nal concentra-
tion of 3 mg of protein/ml; a protein concentration matched to that of
non-chelated, non-dialyzed standard media (7.5% FBS). The concen-
tration range of the individual Zn-de¢cient media used was 0.4^0.65
WM Zn. Portions of this media were supplemented with ZnSO4 to
concentrations of 15 and 50 WM Zn. Analysis of the retinol concen-
tration of the di¡erent Zn media by high performance liquid chroma-
tography indicated a uniform concentration of 0.0113 þ 0.0017 WM,
thereby precluding di¡erences in media retinol as a variable.
2.3. RNA analysis
Total RNA was isolated using the guanidine isothiocyanate method
[19] at the indicated intervals. The total RNA was then quantitated,
denatured and electrophoresed in a 1% agarose-formaldehyde gel,
with subsequent transfer to a Hybond N nylon membrane (Amer-
sham, Arlington Heights, IL, USA) according to standard procedures
[20]. Procedures for prehybridization, hybridization and membrane
washing were performed as we have described previously [21]. Mem-
branes were hybridized with randomly 32P-labeled cDNA probes [20]
for RBP and L-actin (as a normalization control). Following exposure
against ¢lm, the relative amounts of speci¢c mRNAs were determined
by densitometric analysis and normalized to the L-actin signal.
2.4. Protein analysis
To assess RBP protein levels, HepG2 cells were plated and treated
as above. At designated times, cells were rinsed in ice-cold PBS and
then placed in a hypotonic solution (10 mM Tris) and homogenized
using a Dounce homogenizer. The cell lysate was then centrifuged
(15 000Ug for 5 min) and the resultant supernatant fraction was col-
lected. The protein concentration of the supernatant was determined
using the BCA assay kit (Bio-Rad, Hercules, CA, USA) according to
the manufacturer’s instructions. Protein preparations were then sub-
jected to size separation by sodium dodecyl sulfate^polyacrylamide gel
electrophoresis on 12% gels [20], transferred onto polyvinyl diethyl
£uoride membranes and incubated in a blocking solution (5% w/v
Blotto) followed by an overnight incubation with goat anti-human
RBP antibody (Dako, Carpenteria, CA, USA). After washing, mem-
branes were incubated with horseradish peroxidase-labeled rabbit
anti-goat IgG for 1 h [20]. The enzyme bound to RBP was visualized
using enhanced chemiluminescent detection using the ECL kit (Amers-
ham) according to the manufacturer’s instructions. Relative quantities
of RBP and albumin (as a control) were determined by densitometric
analysis.
2.5. DNA analysis
DNA concentrations were ascertained £uorometrically using a com-
mercially available kit (CyQuant, Molecular Probes, Eugene, OR,
USA). DNA was quantitated subsequent to DNase-free RNase
A/T1 pretreatment of cell extracts as described by the manufacturer.
A concentrated DNA standard consisting of sheared calf thymus
DNA at 3 mg/ml was diluted to 1 Wg/ml in a proprietary cell lysis
bu¡er and was used immediately to generate a standard curve. Fluo-
rescence measurements were made using a LS 50B spectro£uorimeter
equipped with a plate reader (Perkin Elmer Corp., Norwalk, CT,
USA) subsequent to the addition of the CyQuant GR intercalator
and a 30 min incubation period. An excitation wavelength of 485
nm and an emission wavelength of 530 nm were chosen and both slits
were set at 2.5 nm width. A 515 nm emission ¢lter was selected to
reduce spectral noise.
2.6. Statistical analysis
One-way analysis of variance (ANOVA) with subsequent post-hoc
comparisons by Sche¡e were performed using Statview (Brainpower
Inc., Calabazas CA, USA). A P value of 90.05 was considered sta-
tistically signi¢cant. Values are presented as the mean þ S.E.M. unless
otherwise indicated.
3. Results
3.1. E¡ect of Zn-de¢cient media on relative RBP transcript
levels in HepG2 cells
A comparison of HepG2 RBP mRNA normalized to L-
actin levels following culture in standard, Zn adequate media
versus Zn-de¢cient (0.5 WM Zn) media is shown in Fig. 1.
Compared to controls in Zn adequate standard media, cells
maintained in the 0.5 WM Zn media exhibited a gradual in-
crease in RBP mRNA levels which was apparent by 48 h, and
ampli¢ed by 72 h at which time RBP mRNA levels were
s 320% higher than controls. The levels of L-actin normalized
RBP mRNA in cells grown in standard (control) media did
not change over the duration of the experiment.
3.2. E¡ect of Zn-de¢cient media on DNA concentration and
RBP transcript levels in HepG2 cells
Zn de¢ciency can be associated with compromised cell via-
bility in vitro [22,23] and in vivo [24]. Thus, time-course ex-
periments were repeated and the DNA content in the dishes
was quanti¢ed along with RBP and L-actin mRNA levels. A
second group treated with 50 WM Zn media was added for
comparison. As depicted in Fig. 2A, treatment with either 0.5
WM or 50 WM Zn media resulted in no change in DNA con-
centration through 72 h compared to cells in Zn adequate,
standard media. When L-actin-normalized RBP mRNA val-
ues were further normalized to DNA (Fig. 2B), the pattern
with respect to RBP transcript levels between the control and
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low Zn group was very similar to that seen in our initial
experiments. By 72 h, cells in 0.5 WM Zn media had RBP
transcript levels that were v330% of controls. RBP mRNA
levels in the 50 WM Zn media group were equivalent to con-
trols at all time points.
3.3. Changes in RBP mRNA and protein levels in response to
varying concentrations of media Zn
Given the e¡ect of Zn de¢ciency on RBP mRNA levels,
further experiments were conducted to examine the dose-de-
pendent relationship between media Zn concentration and
RBP transcript levels. As depicted in Fig. 3A, levels of L-actin
normalized RBP transcripts exhibited both time and Zn con-
centration dependency. RBP transcripts in the 0.5 WM Zn
group progressively increased to 375% and 760% of control
levels at 48 and 72 h, respectively. Levels of RBP mRNA in
the intermediate (15 WM Zn) group increased in a pattern
similar to that of the 0.5 WM group but were only 290% higher
than controls at 72 h. Cells treated with 50 WM Zn had RBP
mRNA values which were similar to untreated controls at all
time points.
Because of the e¡ect of varying media Zn concentrations on
RBP transcript levels, additional experiments were conducted
to determine whether this was manifested by changes in cel-
lular RBP protein levels. As shown in Fig. 3B, cells treated
with 0.5 WM Zn media had signi¢cantly elevated RBP protein
levels by 24 h (6.2-fold relative to untreated controls) which
increased through 72 h to s 8-fold higher than controls. Cells
treated with 15 WM Zn media exhibited a similar progressive
increase in RBP protein levels that was evident by 48 h and
which peaked at 72 h (3-fold higher than controls). Cellular
RBP protein concentrations were similar in the controls
(maintained in unchelated standard growth media) and cells
treated with media containing 50 WM Zn. For comparison,
albumin concentrations were also determined. In contrast to
RBP, no discernible time- or media Zn-dependent pattern was
observed for albumin (Fig. 3C).
3.4. Zn-de¢cient media-induced increases in RBP mRNA can
be abrogated by switching to Zn replete media
Following an initial 72 h culture period in either standard
media or 0.5 WM Zn media, cells were switched to Zn replete
media (chelated media supplemented to 50 WM Zn) for an
additional 24 or 48 h period after which time RBP mRNA
levels were determined. As shown in Fig. 4, cells maintained
continuously in the 0.5 WM Zn media exhibited the predicted
pattern of increase in RBP mRNA following the initial 72 h
exposure period. However, cells switched from the 0.5 WM Zn
to the 50 WM Zn (replete) media and grown for 24 or 48 h had
RBP mRNA levels equivalent to (after 24 h), or even slightly
lower (after 48 h) than cells maintained continuously in stan-
dard growth media.
Fig. 2. E¡ect of Zn-de¢cient media on the DNA concentration and
relative RBP mRNA levels in HepG2 cells. (A) Assessment of DNA
concentration in cells grown in either control Zn adequate standard
media, 50 WM Zn, or 0.5 WM Zn media for the indicated time peri-
ods. (B) E¡ect of Zn-de¢cient media on HepG2 cell RBP mRNA
levels with normalization to L-actin and DNA. Cells were grown in
either standard Zn adequate media, 50 WM Zn, or 0.5 WM Zn media
for the indicated time periods. Each symbol/bar represents the
mean þ S.E.M. from two independent experiments. Asterisks indicate
signi¢cant di¡erences from control cells (*P6 0.05; **P6 0.01;
one-way ANOVA test).
Fig. 1. E¡ect of Zn-de¢cient media on RBP mRNA levels in
HepG2 cells. Cells were grown in either control, Zn adequate (stan-
dard) media or 0.5 WM Zn media for the indicated time periods.
Each bar represents the mean þ S.D. from two independent experi-
ments. Asterisks indicate signi¢cant di¡erences from control cells
(*P6 0.05; **P6 0.01; one-way ANOVA test).
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4. Discussion
While it is known that Zn de¢ciency can be associated with
low plasma retinol concentrations and an elevation in hepatic
RBP, the mechanism(s) underlying the e¡ect of Zn de¢ciency
on vitamin A metabolism are unknown. In the present study,
RBP-expressing HepG2 cells cultured in low Zn media (0.5
WM Zn) had progressively elevated levels of RBP mRNA
beginning at 48 h and continuing to 72 h, relative to cells
grown in standard (control) media. Elevations in transcript
levels of other genes have been observed in response to Zn
de¢ciency in animals [8] and in cell cultures depleted of Zn [6].
Our ¢nding of elevated RBP transcripts in Zn de¢ciency is in
agreement with that of Kimball et al. [15] who reported that
rats fed a Zn-de¢cient diet had increased liver RBP mRNA
levels compared to ad libitum, Zn su⁄cient-fed animals. How-
ever, since hepatic RBP mRNA levels were also increased in
pair-fed animals (albeit to a smaller extent), Kimball and co-
workers concluded that the e¡ect of Zn de¢ciency on RBP
was indirect, resulting from the inanition that accompanied
the Zn de¢ciency [15]. Thus, an objective of the present study
was to determine if the e¡ect of Zn de¢ciency on RBP was
direct.
Although Zn de¢ciency has been reported to promote cell
proliferation [25,26], we [27] and others (see [9] for review)
have shown that Zn de¢ciency is associated with decreased
growth in animals as well as decreased cell viability in vitro
[22,23] and in vivo [24]. Zn de¢ciency has also been shown to
induce apoptosis [18,22,28,29]. Although Zn de¢ciency-in-
duced apoptosis has been observed by 24 h in 3T3 [18] and
rat osteoblast cells [29] in vitro, we observed no di¡erences in
DNA concentration during the 72 h culture period between
the 0.5 WM Zn-, 50 WM Zn- and standard media-treated cells.
Normalization of RBP mRNA levels to DNA demonstrated a
signi¢cant elevation in the abundance of RBP transcripts in
the 0.5 WM Zn cells beginning at 48 h and persisting through
72 h. Cells cultured in 50 WM Zn media had RBP transcripts
per Wg DNA equivalent to controls. Whether the increase in
abundance of RBP mRNA in Zn-de¢cient cultures is a result
Fig. 4. E¡ect of Zn repletion on the Zn-de¢cient media-induced in-
crease in RBP mRNA levels in HepG2 cells. Cells were initially
grown in either standard Zn adequate media or 0.5 WM Zn media
for 72 h (3 days). Following this initial treatment period, the media
were removed, the cells rinsed and the media replaced with either
chelated media supplemented to 50 WM Zn [Zn(+)] or 0.5 WM Zn
media, and the cells allowed to grow for an additional 24 or 48 h
as indicated. RBP mRNA levels were then determined relative to L-
actin as described in Section 2. Each bar represents the mean þ
S.E.M. from two experiments and is shown as a percent of RBP
mRNA levels from cells grown continuously in standard growth me-
dia.
Fig. 3. E¡ect of varying media Zn concentrations on RBP mRNA,
RBP and albumin protein levels in HepG2 cells. (A) E¡ect of de-
creasing media Zn concentrations on RBP mRNA. (B) E¡ect of de-
creasing media Zn concentrations on cellular RBP protein. (C) Ef-
fect of decreasing media Zn concentrations on cellular albumin
levels. Cells were grown in either standard (control) media or 50
WM, 15 WM or 0.5 WM Zn containing media for the indicated times.
Actin-normalized RBP mRNA levels were determined by Northern
blot, intracellular RBP and albumin protein concentrations were de-
termined by Western blot analysis as described in Section 2. Each
bar represents the mean þ S.E.M. from two independent experi-
ments. Asterisks indicate signi¢cant di¡erences from control cells
(*P6 0.05; **P6 0.01; one-way ANOVA test).
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of an increase in the rate of RBP gene transcription, an in-
crease in RBP mRNA half-life, or both remains to be ascer-
tained.
Dose^response studies demonstrated that the increase in
RBP mRNA was dependent on the Zn concentration in the
media. In cells treated with 0.5 WM Zn, the increase in RBP
mRNA by 72 h was greater than in cells treated with an
intermediate (15 WM) Zn concentration. That the increase in
RBP transcripts was speci¢cally due to the low Zn treatment
is demonstrated by the observation that cells grown in the
50 WM Zn media had levels of RBP mRNA equivalent to
that of cells grown in standard control media. The time delay
before the increase in RBP mRNA and the lower extent of
RBP transcript elevation in the 15 WM Zn cells may be a
consequence of slower depletion and/or redistribution of Zn
within intracellular pools. This dose^response relationship
supports the results of previous studies that observed that
even marginal Zn de¢ciency can a¡ect plasma vitamin A con-
centrations [30].
Protein analysis by Western blot showed that cellular levels
of RBP protein increased as the media Zn concentration de-
creased, and that this response was speci¢c to the low Zn
content of the media since no increase was observed in the
cells grown in 50 WM Zn media. That the e¡ect of Zn status is
relatively speci¢c for RBP is suggested by the observation that
albumin levels were not altered by the content of Zn in the
media. Our ¢ndings that the extent of increase in RBP mRNA
and protein in HepG2 cells is negatively correlated with the
concentration of Zn in the media supports a hypothesis that
vitamin A transport is only a¡ected below a certain threshold
level of Zn.
The e¡ect of culture in 0.5 WM Zn media on RBP transcript
levels was observed to be reversible, dependent on the timing
and duration of Zn repletion. Following an initial culture
period in 0.5 WM Zn media, switching the cells to 50 WM
Zn-supplemented media for either 24 or 48 h completely ab-
rogated the increase in RBP mRNA observed in the cells
maintained continuously in the 0.5 WM Zn. Thus, both the
24 and 48 h ‘replete’ cell groups had actin-normalized RBP
mRNA values equivalent to that of cells that were not ex-
posed to the low Zn media. Zn repletion of de¢cient cell
cultures has been observed to restore Zn de¢ciency-induced
elevations in p53 mRNA to normal levels [6] and to inhibit
the apoptotic e¡ects of Zn depletion [29,31]. In animal studies,
restoration of liver and plasma vitamin A levels resulting from
Zn de¢ciency occurred after a time-lag of several days follow-
ing either dietary supplementation or a single, bolus injection
of ZnSO4 [32,33]. In humans, plasma retinol levels were ob-
served to be increased at 6 months following Zn supplemen-
tation [11]. Our observation that the e¡ects of culture in low
Zn media are reversed within 24^48 h by switching to Zn-
supplemented media supports the hypothesis that low Zn sta-
tus directly a¡ects processes involved in RBP synthesis. The
rapidity of the response observed here, in vitro, is likely a
consequence of faster delivery, cellular uptake and redistrib-
ution of the Zn in the absence of physiological factors which
would likely slow these processes in vivo.
We have reported that Zn de¢ciency in vitro results in
markedly elevated production of cellular oxidants and the
subsequent induction of nuclear AP-1 complex activity [18].
Of interest here is our recent observation that the RBP gene
promoter contains an AP-1 site (Jessen and Satre, submitted
for publication) that may become activated under conditions
of oxidant stress. The upregulation of RBP mRNA and pro-
tein levels under these oxidative conditions supports one as-
serted role of vitamin A as a cellular antioxidant [34],
although the antioxidant role of vitamin A in vivo remains
debatable [35]. Nevertheless, our ¢ndings suggest a possible
early sequence of events in which low Zn status-induced in-
creases in AP-1 activity could result in increased RBP gene
transcription and elevated RBP protein.
In summary, culture of HepG2 cells in low Zn media results
in increases in RBP mRNA and protein, with the magnitude
and timing of these increases being governed by the severity of
the reductions in media Zn. These e¡ects on RBP mRNA and
protein occurred without measurable changes in DNA con-
centration. In addition, the Zn de¢ciency-induced elevations
in RBP transcript levels can be rapidly reversed by switching
cells to Zn-supplemented media. These ¢ndings are consistent
with the hypothesis that the reductions in plasma retinol and
simultaneous elevations in hepatic vitamin A observed in Zn
de¢ciency are a direct consequence of reduced Zn status.
Our ¢ndings of increased RBP mRNA and protein under
Zn-de¢cient conditions may re£ect an early and possibly tran-
sitory, physiological response to Zn depletion. Zn de¢ciency
rapidly results in oxidative stress [18] while retinol displays
free radical scavenging activity [34]. Thus, an increase in
RBP could serve to facilitate secretion of retinol into the
circulation as part of an early compensatory response to pro-
tect against oxidative damage. With continued Zn depriva-
tion, this e¡ect on RBP may no longer be manifest or may
become masked. In whole animal studies, prolonged Zn dep-
rivation results in hormonal alterations and reduced food in-
take which may a¡ect vitamin A homeostasis and decrease
plasma retinol.
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